The U.S. Court Of Appeals Says No To Removing Marijuana From Schedule 1— Says That's Up To Congress

The United States Court of Appeals for the Second Circuit ruled that the federal government’s decision to classify cannabis as a Schedule I controlled substance (without any accepted medical utility) is arguably “irrational,” but it is not unconstitutional.

In the case ‘United States of America v. Green’, the defendants argued that cannabis’s scheduling in the US Controlled Substances Act "has no rational basis because cannabis does not meet the statutory criteria for inclusion on Schedule I," reported NORML.

Under the law, Schedule I substances —by definition— must meet three specific criteria: “A high potential for abuse,” “no currently accepted medical use in treatment in the United States,” and “a lack of accepted safety for use (…) under medical supervision."

“The Act’s scheduling criteria are largely irrelevant to our constitutional review because the rational basis test asks only whether Congress could have any conceivable basis for including marijuana on the strictest schedule," said Judges for the US Court of Appeals rejecting the defendant's argument.

"Because there are other plausible considerations that could have motivated Congress’s scheduling of marijuana, we conclude that its classification does not violate the [plaintiffs’] due process or equal protection rights.”

Moreover, Judges acknowledged that the defendants “convincingly argue that it is irrational for the government to maintain that marijuana has no accepted medical use.” Nevertheless, they ruled that the argument is insufficient to compel the Court to determine that cannabis’ Schedule I status is unconstitutional.

“As we have explained,” judges concluded, the defendants in this case “must do more than show that the legislature’s stated assumptions are irrational; [they] must discredit any conceivable basis which could be advanced to support the challenged provision, regardless of whether that basis has a foundation in the record, or actually motivated the legislature.”

This ruling is disappointing, but not unanticipated,” expressed Paul Armentano, NORML’s Deputy Director. “Judges have repeatedly ruled that it is the responsibility of federal lawmakers, not the courts, to repeal the federal prohibition of marijuana. Rather than expect relief from the federal courts, citizens need to continue to pressure their federally elected officials to repeal this admittedly ‘irrational’ and destructive policy.”

Photo: Courtesy Of Matteo Paganelli On Unsplash

Market News and Data brought to you by Benzinga APIs
Posted In: CannabisPoliticsMarketsGeneralACLUCiviqsDes Moines RegisterMichael FrankenNORMLPaul ArmentanoSenator Chuck GrassleyU.S. Food and Drug AdministrationUnited States Court of Appeals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Top Cannabis Event In New Jersey

Join the Benzinga Cannabis Market Spotlight in New Jersey on June 17th! Grow your business, raise money and capitalize on the booming NJ recreational market. Don’t miss this must-attend event in New Brunswick. Secure your tickets now. Very few spots are left. Use the code "JAVIER20" for 20% off!